To date, eL36 (rpL36) plays a role in cisplatin resistance in human carcinoma cells [26], the radiosensitivity in NSCLC (non-small cell lung cancer) cells is regulated by uS3 (rpS3) [27], and eL24 (rpL24) may have effects on drug resistance mechanisms in hepatocellular carcinoma HepG2 cells [28]. This evidence concerns the gene RPL36 and non-small cell lung carcinoma.